Interpreting DAT Imaging Results in the Clinical Context

Interpreting DAT Imaging Results in the Clini...

Suivant

Updates on BTK Inhibitors and Multiple Sclerosis Trials - Part 2

In part two of this series, Dr. Shuvro Roy talks with Drs. Jiwon Oh and Amit Bar-Or about the latest developments in BTK inhibitors for MS, including safety signals, trial results, and future directions. For more information, please read about the abstract that was presented at t ...  Afficher plus

Updates on BTK Inhibitors and Multiple Sclerosis Trials - Part 1

In part one of this series, Dr. Shuvro Roy talks with Drs. Jiwon Oh and Amit Bar-Or about recent multiple sclerosis clinical trial data. For more information, please read about the abstract that was presented at the 2026 AAN Annual Meeting. Read more about the Fenebrutinib Trial. ...  Afficher plus

Épisodes Recommandés

Randomized Trial of Cannabis Extract in Parkinson- Part 1
Neurology Minute

Dr. Jeff Ratliff and Dr. Maureen Leehey discuss the short-term efficacy and tolerability of high-CBD/low-THC cannabis extract on the motor symptoms in patients with Parkinson disease. Show reference: https://movementdisorders.onlinelibrary.wiley.com/doi/10.1002/mds.29768     

Distinguish Parkinson Disease from Functional Parkinsonism
Neurology Minute

Dr. Jeff Ratliff discusses how arm swings can help distinguish Parkinson disease from functional Parkinsonism. Show Reference:  https://movementdisorders.onlinelibrary.wiley.com/doi/10.1002/mdc3.13952   

Dopamine Transporter (DAT) Imaging
Neurology Minute

Dr. Rogan Magee discusses Dopamine Transporter (DAT) Imaging. 

Disclosing the Risk Associated with Isolated REM Behavior Disorder
Neurology Minute

Dr. Jeff Ratliff delves into a conversation around REM sleep behavior disorder and the risks of developing Parkinson disease or parkinsonism disorders.   Show reference: https://movementdisorders.onlinelibrary.wiley.com/doi/10.1002/mdc3.13998?af=R